Published mark
Steris
STERIS plc
NYSE: STE. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:01035e0a-ae92-45e0-a8a0-5331e4a3aef5
- SEC CIK
- 0001757898
- Website
- www.steris-ir.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
- Newest evidence
- Jun 11, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Daniel A. CarestioSince May 29, 2025
- Chair
- Mohsen M. Sohi
- Independent
- 8 / 99 directors published
- Published claims
- 475 distinct sources
- Evidence records
- 140 pinned
- Source conflicts
- 0None open
Built from 5 distinct sources and 14 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
Pierre Boulud seat on Steris, effective 2026-01-01.
EffectiveEffective Jan 1, 2026E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Senior Vice President and President, Healthcare | Cary L. Majors | May 2025 | current | Source reportedE4 |
| President and CEO | Daniel A. Carestio | May 2025 | current | Source reportedE5 |
| Senior Vice President, General Counsel, and Company Secretary | J. Adam Zangerle | May 2025 | current | Source reportedE6 |
| Senior Vice President and General Manager, Life Sciences | Julia K. Madsen | May 2025 | current | Source reportedE7 |
| Vice President and Chief Accounting Officer | Karen L. Burton | May 2025 | current | Source reportedE8 |
| Senior Vice President and General Manager, AST | Kenneth E. Kohler | May 2025 | current | Source reportedE9 |
| Senior Vice President and Chief Human Resources Officer | Mary Clare Fraser | May 2025 | current | Source reportedE10 |
| Senior Vice President and Chief Financial Officer | Michael J. Tokich | May 2025 | current | Source reportedE11 |
| Vice President and Corporate Treasurer | Renato G. Tamaro | May 2025 | current | Source reportedE12 |
Board of directors
Evidence9 directors published. 8 of 9 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Christopher S. Holland | Independent | 2020 | AuditAudit; Compensation and Organization Development · ChairCompensation and Organization Development, chair | Source reportedE3 |
| Cynthia L. Feldmann | Independent | 2005 | AuditAudit; Nominating and Governance · ChairNominating and Governance, chair | Source reportedE3 |
| Daniel A. Carestio | Not independent | 2021 | Compliance and Technology | Source reportedE3 |
| Esther M. Alegria | Independent | 2023 | None published | Source reportedE3 |
| Louis A. Shapiro | Independent | 2025 | AuditAudit; Compliance and TechnologyCompliance and Technology | Source reportedE3 |
| Mohsen M. Sohi | IndependentChair | 2005 | Nominating and Governance | Source reportedE3 |
| Nirav R. Shah | Independent | 2018 | None published | Source reportedE3 |
| Paul E. Martin | Independent | 2021 | AuditAudit; Compensation and Organization DevelopmentCompensation and Organization Development | Source reportedE3 |
| Pierre Boulud | Independent | 2026 | AuditAudit; Compliance and TechnologyCompliance and Technology | Source reportedE3 |
| Dr. Esther M. Alegria | Independence not published | Not published | Compliance and Technology, chairNominating and Governance | Source reportedE13 |
| Dr. Nirav R. Shah | Independence not published | Not published | Compensation and Organization DevelopmentCompliance and Technology | Source reportedE13 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Not published | Christopher S. Holland, Cynthia L. Feldmann, Louis A. Shapiro, Paul E. Martin, Pierre Boulud | Not described in the published record |
| Audit; Compensation and Organization Development | Not published | Paul E. Martin | Not described in the published record |
| Audit; Compensation and Organization Development · Chair | Not published | Christopher S. Holland | Not described in the published record |
| Audit; Compliance and Technology | Not published | Louis A. Shapiro, Pierre Boulud | regulatory |
| Audit; Nominating and Governance · Chair | Not published | Cynthia L. Feldmann | Not described in the published record |
| Compensation and Organization Development | Christopher S. Holland | Christopher S. Holland, Dr. Nirav R. Shah, Paul E. Martin | Not described in the published record |
| Compliance and Technology | Dr. Esther M. Alegria | Dr. Esther M. Alegria, Daniel A. Carestio, Dr. Nirav R. Shah, Louis A. Shapiro, Pierre Boulud | regulatory |
| Nominating and Governance | Cynthia L. Feldmann | Cynthia L. Feldmann, Dr. Esther M. Alegria, Mohsen M. Sohi | Not described in the published record |
Committee RecordAudit: Chair not stated; Members Christopher S. Holland; Cynthia L. Feldmann; Louis A. Shapiro; Paul E. Martin; Pierre Boulud
Committee AppointmentChristopher S. Holland: member, Audit
Committee AppointmentCynthia L. Feldmann: member, Audit
Committee AppointmentLouis A. Shapiro: member, Audit
Committee AppointmentPaul E. Martin: member, Audit
Committee AppointmentPierre Boulud: member, Audit
Committee AppointmentChristopher S. Holland: chair, Compensation and Organization Development
Committee AppointmentDr. Nirav R. Shah: member, Compensation and Organization Development
Committee AppointmentPaul E. Martin: member, Compensation and Organization Development
Committee AppointmentDr. Esther M. Alegria: chair, Compliance and Technology
Committee AppointmentDaniel A. Carestio: member, Compliance and Technology
Committee AppointmentDr. Nirav R. Shah: member, Compliance and Technology
Committee AppointmentLouis A. Shapiro: member, Compliance and Technology
Committee AppointmentPierre Boulud: member, Compliance and Technology
Committee RecordNominating and Governance: Chair Cynthia L. Feldmann; Members Cynthia L. Feldmann (Chair); Dr. Esther M. Alegria; Mohsen M. Sohi
Committee AppointmentCynthia L. Feldmann: chair, Nominating and Governance
Committee AppointmentDr. Esther M. Alegria: member, Nominating and Governance
Committee AppointmentMohsen M. Sohi: member, Nominating and Governance
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerDaniel A. Carestio, President and CEO, from May 29, 2025
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceIndex MembershipS&P 500 (SPX)
Security ListingSTE (NYSE)
Index memberships1 membership attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPX
Source reportedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NYSE: STE | current | Dec 23, 2019 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameSTERIS plc
Entity StatusPublic listing published
Official Websitehttps://www.steris-ir.com
Published FactUS
Published FactIreland
Published FactHealthcare
Published Facthttps://www.steris-ir.com
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Cary L. MajorsSenior Vice President and President, Healthcarecompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:18
- Daniel A. CarestioPresident and CEO; Directorcompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:19, company:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:12
- J. Adam ZangerleSenior Vice President, General Counsel, and Company Secretarycompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:20
- Julia K. MadsenSenior Vice President and General Manager, Life Sciencescompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:21
- Karen L. BurtonVice President and Chief Accounting Officercompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:22
- Kenneth E. KohlerSenior Vice President and General Manager, ASTcompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:23
- Mary Clare FraserSenior Vice President and Chief Human Resources Officercompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:24
- Michael J. TokichSenior Vice President and Chief Financial Officercompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:25
- Renato G. TamaroVice President and Corporate Treasurercompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:26
- Christopher S. HollandIndependent Directorcompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:10
- Cynthia L. FeldmannIndependent Directorcompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:11
- Esther M. AlegriaIndependent Directorcompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:13
- Louis A. ShapiroIndependent Directorcompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:14
- Mohsen M. SohiChaircompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:9
- Nirav R. ShahIndependent Directorcompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:15
- Paul E. MartinIndependent Directorcompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:16
- Pierre BouludDirectorcompany:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:leadership_role:17
- Dr. Esther M. AlegriaDirector (committee appointment)company:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:committee_record:37
- Dr. Nirav R. ShahDirector (committee appointment)company:01035e0a-ae92-45e0-a8a0-5331e4a3aef5:committee_record:33
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 14 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 6 Claims.
- E2STERIS plc Form 10-K (filed 2026-05-29). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec proxy. Published Jun 11, 2026. Retrieved Jul 28, 2026. Cited by 9 Claims.
- E4sec filing. Published May 29, 2025. Retrieved May 13, 2026. Cited by 1 Claim.
- E5sec filing. Published May 29, 2025. Retrieved May 13, 2026. Cited by 1 Claim.
- E6sec filing. Published May 29, 2025. Retrieved May 13, 2026. Cited by 1 Claim.
- E7sec filing. Published May 29, 2025. Retrieved May 13, 2026. Cited by 1 Claim.
- E8sec filing. Published May 29, 2025. Retrieved May 13, 2026. Cited by 1 Claim.
- E9sec filing. Published May 29, 2025. Retrieved May 13, 2026. Cited by 1 Claim.
- E10sec filing. Published May 29, 2025. Retrieved May 13, 2026. Cited by 1 Claim.
- E11sec filing. Published May 29, 2025. Retrieved May 13, 2026. Cited by 1 Claim.
- E12sec filing. Published May 29, 2025. Retrieved May 13, 2026. Cited by 1 Claim.
- E13board_seats. sp500-board-director-completeness-remediation-2026-05-15. Cited by 20 Claims.
- E14Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026- Pierre Boulud seat on Steris, effective 2026-01-01.
- Pierre Boulud member of Audit; Compliance and Technology, effective 2026-01-01.
- Cary L. Majors executive of Steris, effective 2025-05-29.
- Daniel A. Carestio executive of Steris, effective 2025-05-29.
- J. Adam Zangerle executive of Steris, effective 2025-05-29.
- Julia K. Madsen executive of Steris, effective 2025-05-29.
- Karen L. Burton executive of Steris, effective 2025-05-29.
- Kenneth E. Kohler executive of Steris, effective 2025-05-29.
- Mary Clare Fraser executive of Steris, effective 2025-05-29.
- Michael J. Tokich executive of Steris, effective 2025-05-29.
- Renato G. Tamaro executive of Steris, effective 2025-05-29.
- Louis A. Shapiro seat on Steris, effective 2025-01-01.
- Audit; Compliance and Technology committee of Steris, effective 2025-01-01.
- Louis A. Shapiro member of Audit; Compliance and Technology, effective 2025-01-01.
- Esther M. Alegria seat on Steris, effective 2023-01-01.
- Daniel A. Carestio seat on Steris, effective 2021-01-01.
- Paul E. Martin seat on Steris, effective 2021-01-01.
- Audit; Compensation and Organization Development committee of Steris, effective 2021-01-01.
- Paul E. Martin member of Audit; Compensation and Organization Development, effective 2021-01-01.
- Daniel A. Carestio member of Compliance and Technology, effective 2021-01-01.
- Christopher S. Holland seat on Steris, effective 2020-01-01.
- Audit; Compensation and Organization Development · Chair committee of Steris, effective 2020-01-01.
- Christopher S. Holland member of Audit; Compensation and Organization Development · Chair, effective 2020-01-01.
- Nirav R. Shah seat on Steris, effective 2018-01-01.
- Cynthia L. Feldmann seat on Steris, effective 2005-01-01.
- Mohsen M. Sohi seat on Steris, effective 2005-01-01.
- Mohsen M. Sohi chairs board Steris, effective 2005-01-01.
- Audit; Nominating and Governance · Chair committee of Steris, effective 2005-01-01.
- Cynthia L. Feldmann member of Audit; Nominating and Governance · Chair, effective 2005-01-01.